| Dr Christine Rose Nevin-woods, DO | |
|
1525 Blue Spruce Dr, Fort Collins, CO 80524-2004 | |
| (970) 498-6719 | |
| (970) 498-6745 |
| Full Name | Dr Christine Rose Nevin-woods |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 1525 Blue Spruce Dr, Fort Collins, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154469864 | NPI | - | NPPES |
| 01290824 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 29082 (Colorado) | Secondary |
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 29082 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christine Rose Nevin-woods, DO 1525 Blue Spruce Dr, Fort Collins, CO 80524-2004 Ph: (970) 498-6719 | Dr Christine Rose Nevin-woods, DO 1525 Blue Spruce Dr, Fort Collins, CO 80524-2004 Ph: (970) 498-6719 |
News Archive
More women fighting cancers such as breast, lung, colorectal and ovarian can now help prevent the nausea and vomiting associated with their treatment of moderately emetogenic (vomit-inducing) cancer chemotherapy. Although new treatment entities have been developed in the past 10 years for control of chemically-induced nausea and vomiting, CINV remains a significant problem in the context of current practice.
One of the biggest problems in the current treatment of cancer is that the agents that are efficacious in the destruction of tumorous cells are, at the same time, extremely toxic for the rest of the healthy cells and tissues of the patient.
Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases today announced that data from the Company's Phase 3 clinical trial of its pharmaceutical grade L-glutamine (PGLG) treatment for sickle cell anemia and sickle beta-0 thalassemia, will be presented, during the 9th Annual Sickle Cell Disease Research and Educational Symposium and 38th National Sickle Cell Disease Scientific Meeting.
The Staphylococcus aureus bacterium is one of the commonest pathogens and can even cause sepsis. The new antibiotic dalbavancin is very effective against many bacterial pathogens.
› Verified 8 days ago
Dr. Anupama Anugraha Das, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2938 Hearthstone Dr, Fort Collins, CO 80528 Phone: 970-371-7236 | |
Dr. Kevin J O'toole, DO, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4674 Snow Mesa Dr Ste 200, Fort Collins, CO 80528 Phone: 970-495-8450 Fax: 970-297-7674 | |
Kevin O'connell, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4674 Snow Mesa Dr, Ste 200, Fort Collins, CO 80528 Phone: 970-495-7450 Fax: 970-297-6599 | |
Dr. Bruce Raymond Belleville, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2831 Skimmerhorn St, Fort Collins, CO 80526 Phone: 970-223-2274 | |
Tracey Stefanon, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4674 Snow Mesa Dr, Suite 200, Fort Collins, CO 80528 Phone: 970-495-8450 Fax: 970-297-6599 | |
Mr. Brian James Thompson, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 620 S Lemay Ave, Fort Collins, CO 80524 Phone: 970-482-6620 Fax: 970-482-6626 | |
Baylee Blair, RN Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1525 Blue Spruce Dr, Fort Collins, CO 80524 Phone: 970-837-6736 |